1. Home
  2. ZBH vs ILMN Comparison

ZBH vs ILMN Comparison

Compare ZBH & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZBH
  • ILMN
  • Stock Information
  • Founded
  • ZBH 1927
  • ILMN 1998
  • Country
  • ZBH United States
  • ILMN United States
  • Employees
  • ZBH N/A
  • ILMN N/A
  • Industry
  • ZBH Industrial Specialties
  • ILMN Medical Specialities
  • Sector
  • ZBH Health Care
  • ILMN Health Care
  • Exchange
  • ZBH Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • ZBH 19.1B
  • ILMN 16.9B
  • IPO Year
  • ZBH N/A
  • ILMN 2000
  • Fundamental
  • Price
  • ZBH $92.04
  • ILMN $97.76
  • Analyst Decision
  • ZBH Hold
  • ILMN Buy
  • Analyst Count
  • ZBH 20
  • ILMN 17
  • Target Price
  • ZBH $112.33
  • ILMN $127.00
  • AVG Volume (30 Days)
  • ZBH 1.8M
  • ILMN 2.4M
  • Earning Date
  • ZBH 08-07-2025
  • ILMN 07-31-2025
  • Dividend Yield
  • ZBH 1.04%
  • ILMN N/A
  • EPS Growth
  • ZBH N/A
  • ILMN N/A
  • EPS
  • ZBH 4.51
  • ILMN 7.91
  • Revenue
  • ZBH $7,698,500,000.00
  • ILMN $4,284,000,000.00
  • Revenue This Year
  • ZBH $7.64
  • ILMN N/A
  • Revenue Next Year
  • ZBH $5.64
  • ILMN $2.78
  • P/E Ratio
  • ZBH $20.42
  • ILMN $12.35
  • Revenue Growth
  • ZBH 3.30
  • ILMN N/A
  • 52 Week Low
  • ZBH $89.22
  • ILMN $68.70
  • 52 Week High
  • ZBH $116.71
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • ZBH 43.95
  • ILMN 47.64
  • Support Level
  • ZBH $89.33
  • ILMN $92.19
  • Resistance Level
  • ZBH $97.92
  • ILMN $111.00
  • Average True Range (ATR)
  • ZBH 2.03
  • ILMN 4.08
  • MACD
  • ZBH -0.46
  • ILMN -1.22
  • Stochastic Oscillator
  • ZBH 31.55
  • ILMN 29.61

About ZBH Zimmer Biomet Holdings Inc.

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: